Higher vs. Lower Dose Heparin for PCI
Recruiting
N/A
Interventional Study
Cardiovascular Diseases
Percutaneous Coronary Intervention
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 16,000 (estimated)
- Sponsor
- Population Health Research Institute · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
HD PCI is a multicenter, randomized, registry-based, cluster crossover design trial of higher dose versus lower dose heparin in patients undergoing elective percutaneous coronary intervention (PCI).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
\- Patients undergoing elective PCI
Exclusion Criteria:
* Age \<18 years
* Planned chronic total occlusion PCI
* Non-resident precluding follow up through local registries
Hospital (Cluster) Eligibility Criteria
Hospitals will be eligible to participate if they meet the foll…
Contacts